新達控股(08471.HK)擬600萬港元出售廣州半城雲19.23%股權
格隆匯12月3日丨新達控股(08471.HK)發佈公吿,有關公司於廣州半城雲信息科技有限公司(“廣州半城雲”)的投資。2021年12月3日,公司間接全資附屬駿達企業控股有限公司(作為賣方)與新浩科技有限公司(作為買方)訂立買賣協議,據此,買方同意購買廣州半城雲的19.23%股權(相當於集團持有的廣州半城雲全部股權),代價為600萬港元。
出售事項須待集團進行內部重組後作實,其中,集團所持廣州半城雲股權將於出售事項完成前,內部轉讓予賣方持有的新註冊成立的企業工具。待重組完成後,預期出售事項將於2022年3月31日完成。出售事項完成後,集團將不再持有任何廣州半城雲權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.